Pa Shun International Holdings Limited (0574.HK)
HKD 0.04
(0.0%)
HKD 0.04
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 322.66 Million CNY | 28.24% |
| 2022 | 251.6 Million CNY | 0.01% |
| 2021 | 251.59 Million CNY | 11.72% |
| 2020 | 225.2 Million CNY | -7.05% |
| 2019 | 242.28 Million CNY | -11.13% |
| 2018 | 272.63 Million CNY | -31.5% |
| 2017 | 397.98 Million CNY | 5.93% |
| 2016 | 375.71 Million CNY | 110.34% |
| 2015 | 178.62 Million CNY | -80.37% |
| 2014 | 910.04 Million CNY | 8.88% |
| 2013 | 835.81 Million CNY | 30.75% |
| 2012 | 639.25 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 291.52 Million CNY | 0.0% |
| 2024 Q1 | 291.52 Million CNY | -9.65% |
| 2023 Q3 | 322.66 Million CNY | 19.97% |
| 2023 Q1 | 244.75 Million CNY | -2.72% |
| 2023 Q2 | 268.94 Million CNY | 9.89% |
| 2023 FY | 322.66 Million CNY | 28.24% |
| 2023 Q4 | 322.66 Million CNY | 0.0% |
| 2022 Q4 | 251.6 Million CNY | 10.73% |
| 2022 Q3 | 227.21 Million CNY | -5.56% |
| 2022 Q2 | 240.59 Million CNY | 0.0% |
| 2022 FY | 251.6 Million CNY | 0.01% |
| 2022 Q1 | 240.59 Million CNY | -4.37% |
| 2021 Q4 | 251.59 Million CNY | 11.46% |
| 2021 Q2 | 244.25 Million CNY | 0.0% |
| 2021 Q1 | 244.25 Million CNY | 8.46% |
| 2021 FY | 251.59 Million CNY | 11.72% |
| 2021 Q3 | 225.72 Million CNY | -7.59% |
| 2020 Q2 | 293.75 Million CNY | 0.0% |
| 2020 FY | 225.2 Million CNY | -7.05% |
| 2020 Q4 | 225.2 Million CNY | 0.0% |
| 2020 Q3 | 225.2 Million CNY | -23.34% |
| 2020 Q1 | 293.75 Million CNY | 21.25% |
| 2019 Q2 | 259.68 Million CNY | 0.0% |
| 2019 Q1 | 259.68 Million CNY | -4.75% |
| 2019 FY | 242.28 Million CNY | -11.13% |
| 2019 Q4 | 242.28 Million CNY | 0.0% |
| 2019 Q3 | 242.28 Million CNY | -6.7% |
| 2018 Q3 | 272.63 Million CNY | -28.8% |
| 2018 Q2 | 382.94 Million CNY | 0.0% |
| 2018 Q1 | 382.94 Million CNY | -3.78% |
| 2018 FY | 272.63 Million CNY | -31.5% |
| 2018 Q4 | 272.63 Million CNY | 0.0% |
| 2017 FY | 397.98 Million CNY | 5.93% |
| 2017 Q1 | 371.58 Million CNY | -1.1% |
| 2017 Q3 | 397.98 Million CNY | 7.1% |
| 2017 Q2 | 371.58 Million CNY | 0.0% |
| 2017 Q4 | 397.98 Million CNY | 0.0% |
| 2016 Q2 | 213.67 Million CNY | 13.87% |
| 2016 Q1 | 187.64 Million CNY | 5.05% |
| 2016 FY | 375.71 Million CNY | 110.34% |
| 2016 Q4 | 375.71 Million CNY | 0.0% |
| 2016 Q3 | 375.71 Million CNY | 75.84% |
| 2015 FY | 178.62 Million CNY | -80.37% |
| 2015 Q3 | 152.15 Million CNY | -32.89% |
| 2015 Q1 | 199.8 Million CNY | -78.04% |
| 2015 Q2 | 226.71 Million CNY | 13.47% |
| 2015 Q4 | 178.62 Million CNY | 17.4% |
| 2014 FY | 910.04 Million CNY | 8.88% |
| 2014 Q4 | 910.04 Million CNY | 70.83% |
| 2014 Q3 | 532.71 Million CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2013 FY | 835.81 Million CNY | 30.75% |
| 2012 FY | 639.25 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| China Healthwise Holdings Limited | 145.27 Million HKD | -122.111% |
| Tycoon Group Holdings Limited | 445.4 Million HKD | 27.557% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 413.75 Million HKD | 22.015% |